Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)
Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)
Recruiting · NCT06602011 · Registry updated 2024-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002) | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not stated | 2024-10-15 | NCT06602011 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fujian Provincial Hospital | 45 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| First Affiliated Hospital of Fujian Medical University | Fuzhou | China | 5 |
| First Affiliated Hospital of Xiamen University | Xiamen | China | 2 |
| Fujian Provincial Hospital | Fuzhou | China | 14 |
| Mengchao Hepatobiliary Hospital of Fujian Medical University | Fuzhou | China | 8 |
| Zhangzhou Affiliated Hospital of Fujian Medical University | Zhangzhou | China | 3 |
| Zhongshan Hospital of Xiamen University | Xiamen | China | 2 |